摘要
近年来,我国胸痛中心建设数量迅速提升。截至2022年12月,全国胸痛中心注册单位5417家,通过验收2241家,共救治急性胸痛患者1151万例。其中2022年全国胸痛中心救治急性胸痛患者超274万例,其中急性心肌梗死超58万例,取得了积极成效:显著提高了ST段抬高型心肌梗死患者的再灌注治疗比例,保证短时间内对心肌梗死患者进行救治,并缩短了患者住院时间,降低了患者住院费用及死亡率。通过胸痛中心建设,显著优化救治流程,改善患者预后。当下,全国胸痛中心的建设及质控工作仍需进一步推进,部分区域胸痛中心建设比例和胸痛诊疗水平有待提高,患者延误依然是我国急性胸痛救治面临的重要挑战。
In recent years,the number of Chest Pain Centers in China has increased rapidly.As of December 2022,there were 5417 registered units of Chest Pain Centers nationwide,2241 of which had passed the acceptance,and a total of 11.51 million patients with acute chest pain were treated.The Chest Pain Centers treated more than 2.74 million patients with acute chest pain in 2022,including more than 580,000 patients with acute myocardial infarction,and achieved positive results:signifi cantly increasing the proportion of reperfusion therapy for ST-segment elevation myocardial infarction patients,ensuring the treatment of myocardial infarction patients in a short time,shortening the length of patient hospitalization,and reducing the hospitalization costs and mortality of patients.Through the construction of chest pain center,the treatment process was signifi cantly optimized and the prognosis of patients was improved.At present,the construction and quality control of Chest Pain Centers still need to be further promoted.In some areas,the construction proportion of Chest Pain Centers and the level of diagnosis and treatment of chest pain need to be improved.patient delay is still an important challenge for the treatment of acute chest pain in China.
出处
《中国介入心脏病学杂志》
CSCD
2023年第11期820-827,共8页
Chinese Journal of Interventional Cardiology
关键词
胸痛中心
质控报告
急性ST段抬高型心肌梗死
Chest Pain Center
Quality control report
Acute ST-segment elevation myocardial infarction
